MV
Michael Vincent Meluzio sold $169K of CUE stock
Michael Vincent Meluzio, VP, Prin. Accounting Officer of Cue Biopharma, Inc. (CUE), sold 5,628 shares of CUE stock worth $169K, per an SEC Form 4 filed Aug 17, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 13, 2026, 4 days before it was made public.
CUE has moved -48.1% since the trade date, from $31.08 to $16.12 (Nov 13, 2026 close).
- Traded
- Aug 13, 2026
- Disclosed
- Aug 17, 2026
- Filing delay
- 4 days
- Price since
- -48.1%
- Role
- VP, Prin. Accounting Officer
- Source
- SEC Form 4